Vinconate
From Wikipedia, the free encyclopedia
 |
|
|
Vinconate
|
|
| Systematic (IUPAC) name | |
| (±)-3-Ethyl-2,3,3α,4-tetrahydro- 1H-indolo[3,2,1-de] [1,5]naphthyridine-6-carboxylic acid methyl ester | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H20N2O2 |
| Mol. mass | 296.37 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Vinconate is a synthetic vincamine analog used as a nootropic
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
